Literature DB >> 9006790

Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia.

B May1, H D Kuntz, M Kieser, S Köhler.   

Abstract

The efficacy and safety of the standardized herbal combination preparation of Enteroplant, consisting of peppermint oil (90 mg) and caraway (50 mg) in an enteric coated capsule, have been studied in a double-blind, placebo-controlled multicentre trial in patients with non-ulcer dyspepsia. A total of 45 patients were included in the trial after thorough physical and gastro-enterological examination. The primary outcome variables were the change in the intensity of pain and the global clinical impression (Clinical Global Impression [CGI], Item 2), which were evaluated for 39 patients (test preparation: 19, placebo: 20). After four weeks of treatment both target parameters were significantly improved for the group of patients treated with the peppermint oil/caraway oil combination compared to the placebo group (p = 0.015 and 0.008, respectively). Before the start of treatment all patients in the test preparation group reported moderate to severe pain, while by the end of the study 63.2% of these patients were free of pain. The pain symptoms had improved in a total of 89.5% of the patients in the active treatment group. After 4 weeks the Clinical Global Impressions were improved for 94.5% of the patients treated with the peppermint oil/caraway oil combination. The trial medication was also superior to placebo with respect to pain frequency, medical prognosis, the severity of the disorder and the efficacy index (CGI, Items 1 and 3), which were adopted as secondary end-points for evaluation of efficacy. There were similarly favourable findings for the herbal combination, compared with placebo, with respect to the reduction of other gastrointestinal symptoms. The combination preparation was found to be excellently tolerated. There was a total of 7 adverse events (test preparation: 4, placebo: 3), with a causal association with the treatment being ascribed in one case for the test preparation group and one case for the placebo group.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9006790

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  8 in total

Review 1.  [Functional dyspepsia - diagnosis of desperation?].

Authors:  T Liebregts; B Adam; G Holtmann
Journal:  Internist (Berl)       Date:  2006-06       Impact factor: 0.743

Review 2.  Management of functional dyspepsia: Unsolved problems and new perspectives.

Authors:  Ahmed Madisch; Stephan Miehlke; Joachim Labenz
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

Review 3.  Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review.

Authors:  Nazanin Momeni Roudsari; Naser-Aldin Lashgari; Saeideh Momtaz; Mohammad Hosein Farzaei; André M Marques; Amir Hossein Abdolghaffari
Journal:  Daru       Date:  2019-07-04       Impact factor: 3.117

4.  Antiperistaltic effect and safety of L-menthol for esophagogastroduodenoscopy in the elderly with contraindication to hyoscine-N-butylbromide.

Authors:  Tsung-Chieh Yang; Ping-Hsien Chen; Ming-Chih Hou; Li-Ning Peng; Ming-Hsien Lin; Liang-Kung Chen; Yi-Hsiang Huang
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

5.  The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome.

Authors:  Shahin Merat; Shadi Khalili; Pardise Mostajabi; Anahita Ghorbani; Reza Ansari; Reza Malekzadeh
Journal:  Dig Dis Sci       Date:  2009-06-09       Impact factor: 3.199

Review 6.  Aromatherapy for treatment of postoperative nausea and vomiting.

Authors:  Sonia Hines; Elizabeth Steels; Anne Chang; Kristen Gibbons
Journal:  Cochrane Database Syst Rev       Date:  2018-03-10

Review 7.  Herbs and Spices in the Treatment of Functional Gastrointestinal Disorders: A Review of Clinical Trials.

Authors:  Amanda C Fifi; Cara Hannah Axelrod; Partha Chakraborty; Miguel Saps
Journal:  Nutrients       Date:  2018-11-09       Impact factor: 5.717

8.  Cumin extract for symptom control in patients with irritable bowel syndrome: a case series.

Authors:  Shahram Agah; Amir Mehdi Taleb; Reyhane Moeini; Narjes Gorji; Hajar Nikbakht
Journal:  Middle East J Dig Dis       Date:  2013-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.